Defense Health Agency Contracting Activity - DHACA

Description

This MMRDA mechanism is intended to support a logical continuation of previously funded, prior year research or development efforts relevant to the above FY22 JWMRP Focus Areas with the highest potential to augment and accelerate medical product development and healthcare solutions for military Service Members, Veterans, their families, other MHS beneficiaries, and/or the American public. The USAMRDC will implement this research program through the awarding of assistance agreements (grants and cooperative agreements), research contracts, or Other Transaction Agreements (OTAs). All invited applicants must submit full applications in accordance with the procedures outlined in this funding opportunity announcement. Collaboration with DOD organizations is encouraged when this alliance would contribute to the success of the research effort, and any funds designated for DOD laboratories or activities should be identified in the application through submission of a “Suggested Collaborating DOD Military Facility Budget Format,” Attachment 15. Funding from this award mechanism may be used for a wide range of research projects spanning preclinical studies, translational and technology development, clinical studies (including correlative studies and initial safety and efficacy testing of promising drug and vaccine candidates, medical devices and technologies), and phase 1, phase 2, or phase 3 clinical trials.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org